The a-ketoglutarate-dependent dioxygenase aspartyl (asparaginyl) J-hydroxylase (EC 1.14. (18, 19) . A cDNA fragment (nt 1-1033) was deleted from bovine Asp (Asn) /3hydroxylase cDNA by digestion with Pst I and ligated to form pNC3d-1. A 1.4-kb cDNA insert [nt 1034-2498, containing a 233-bp 3' untranslated region (19)] resulting from Xba I/Xho I digestion was isolated and then cloned into an E. coli expression vector, pFLAG-1 (IBI) (20) , to form p52-1.
ketoglutarate.
Many proteins from both vertebrates and invertebrates that function extracellularly as either integral components of the plasma membrane or as soluble components of plasma possess discrete domains with a characteristic pattern of three disulfide bonds as found in epidermal growth factor (EGF) (1) (2) (3) (4) (5) . There is increasing evidence that these EGF-like domains are involved in protein-protein interactions (6) (7) (8) (9) (10) . In several cases, these intermolecular interactions have been shown to be Ca2+ dependent (9) (10) (11) (12) (13) (14) (15) .
In many of the EGF-like domains that can potentially bind CaW+, a specific aspartic or asparagine residue has been shown to be posttranslationally hydroxylated (4) . Despite the location of EGF domains within a region of their respective proteins that is likely to be required for biologic activity, the physiologic role of the 3-hydroxyl modification has not been defined. One approach to addressing this question involves the specific inhibition of hydroxylation within these EGF domains without alterations in their primary sequences or changes in other posttranslational modifications. As a first step toward the development of specific hydroxylation inhibitors, we have sought to elucidate the enzymology involved in this modification. Following the demonstration of aspartyl hydroxylation in a cell-free system (16) , this a-ketoglutarate-dependent dioxygenase (16, 17) was purified from bovine liver (18) ; its cDNA was cloned and its biologic activity was expressed in an in vitro translation system (19) . The enzyme aspartyl (asparaginyl) f-hydroxylase [peptide-L-aspartate,2-oxoglutarate:oxygen oxidoreductase (3-hydroxylating)] contains a relatively compact C-terminal catalytic domain and an extended N terminus. The present studies describe the expression in Escherichia coli, purification, and characterization of a fully active catalytic domain of bovine Asp (Asn) 3-hydroxylase. In addition, evidence for the identification of an active-site region is presented that may facilitate further studies for the entire family of vertebrate a-ketoglutarate-dependent dioxygenases.
MATERIALS AND METHODS Construction of a Plasmid (p52) for Expression of a 52,000-Da Asp (Asn) 3-Hydroxylase (P52). The cDNA coding for P52 is located between nt 931 and 2265 (18, 19) . A cDNA fragment (nt 1-1033) was deleted from bovine Asp (Asn) /3hydroxylase cDNA by digestion with Pst I and ligated to form pNC3d-1. A 1.4-kb cDNA insert [nt 1034-2498, containing a 233-bp 3' untranslated region (19) ] resulting from Xba I/Xho I digestion was isolated and then cloned into an E. coli expression vector, pFLAG-1 (IBI) (20) , to form p52-1.
Since this 1.4-kb cDNA insert lacked nt 931-1033, a synthetic double-stranded DNA fragment containing these nucleotides, a HindIII site at the 5' end, and a Pst I site at the 3' end was inserted into p52-1 to form the expression plasmid p52. The cDNA reading frame (nt 931-2265) ofp52 was confirmed as follows: p52 was then used to transform E. coli DHSaF'IQ (BRL); it was then purified and the 5' ends ofthe cDNA insert were sequenced. Purified p52 was introduced into both a normal E. coli strain and a protease-deficient strain (BL21; Novagen).
Expression of P52. A p52 transformant was grown at 37TC in 3 x LB medium (30 g oftryptone, 15 Site-Directed Mutagenesis. The HindIII-Xho I firgment from p52 was subcloned into the HindIII/Sal I sites of pALTER-1 and the Altered Sites in vitro mutagenesis system (Promega) was employed. Histidine-675 (codon CAC) was changed to alanine (codon GCC) by using a 31-base synthetic oligonucleotide. The mutation was identified through DNA sequencing using Sequenase version 2.0 (United States Biochemical) (23) and the entire H675A-P52 gene was sequenced to confirm that there were no additional mutations. The H675A DNA HindIII-Xba I insert from the pALTER-1 mutagenesis plasmid was then subcloned back into the expression vector pFLAG-1 and used to transform E. coli strain BL21. The cell pellet from a 1-liter culture was suspended in 50 mM Tris HCl (pH 7.0), lysed by addition of lysozyme (1 mg/ml), and frozen at -70°C for 20 min. DNase I (BRL) was added to the thawed lysates. After centrifugation at 12,400 x g for 10 min, the supernatant was applied to an Anti-FLAG M2 affinity gel column as per instructions from IBI, except that 50 mM Tris'HCl (pH 7.0) was substituted for phosphatebuffered saline. The protein was eluted from the column with FLAG peptide at 150 pLg/ml in 50 mM Tris HCl (pH 8.0). Column fractions containing mutant P52 were identified by Western blot analysis (18, 19) and were assessed for purity by SDS/PAGE. Mutant P52 fractions were %30%6 pure and were assayed for Asp (Asn) ,B-hydroxylase activity (18) (Fig. 1) . The structures of these peptides were determined by N-terminal sequence analysis and mass spectral analysis and corroborated by monitoring the release of radioactivity at each cycle of Edman degradation (Table 2 ). In all cases the release of radioactivity corresponded to the release of S-acetamidocysteine. The results indicated that all seven cysteine residues were modified to a similar extent. The finding that the number of sites labeled exceeds the stoichiometry of iodoacetamide modification (7 versus 5) suggests that after modification of five cysteine residues, the reactivity of the two remaining potential sites becomes reduced.
Since the cysteine residues were labeled proportionally to the loss ofenzymatic activity, it was difficult to discern which cysteine modifications contributed the most to enzyme inactivation. The presence of micromolar a-ketoglutarate protected P52 against iodoacetamide inactivation (Table 3 ) and prevented the incorporation of radioactivity from iodo[14C]acetamide at all sites of modification (Fig. 1B) (0) of 50 pM Fe2+ plus 200 pM a-ketoglutarate (caKG). Regions A-G containing fractions with the major amounts of radioactivity were submitted for N-terminal sequence analysis and mass spectral analysis (Table 2) . (18) . Although 80%o protection (remaining activity) was observed under these conditions (Table 3 ), higher levels of protection were not attained even when millimolar a-ketoglutarate was used (data not shown). Fe2+ alone offered no protection but in the presence of a-ketoglutarate, complete protection was observed (Table 3 ). These results suggested that binding of a-ketoglutarate to the enzyme was mediated by a metal ion [as has been proposed for other a-ketoglutarate-dependent dioxygenases on the basis of kinetic studies (25) ], and, in the absence of added Fe2+, limiting adventitious metal ion was utilized. Consistent with this explanation, in The results of the chemical modification studies are not uniquely consistent with the cysteine residues having a direct role in catalysis. However, since protection from both enzyme inactivation and cysteine modification was observed with a substrate common to all of the a-ketoglutaratedependent dioxygenases, the primary structure in the immediate vicinity of each of the labeled cysteines of Asp (Asn)
,-hydroxylase was compared with the primary structures within this family of enzymes. Initial inspection of the region between cysteine-656 and cysteine-681 suggested homology between residues 657-684 of Asp (Asn) 3-hydroxylase and residues 693-718 of human lysyl hydroxylase that was independently corroborated (see below). Since these sequences
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Human Prolyl Human Lysyl Chicken Lysyl Bovine Aspartyl are located within the C-terminal region of their respective proteins, we focused upon this region within the vertebrate a-ketoglutarate-dependent dioxygenases. A pairwise alignment of the C-terminal regions of human prolyl (a-subunit) hydroxylase (26) and lysyl hydroxylase (27) and a pairwise alignment of the C-terminal regions of lysyl hydroxylase and bovine aspartyl hydroxylase (19) could be generated and corroborated by a multiple sequence alignent that includes the C-terminal regions from chicken prolyl (28) and lysyl (29) hydroxylases (Fig. 2) . This resulted in the alignment of the "His-2" motifs previously proposed to exist in prolyl and lysyl hydroxylase (31) and the corresponding His-2 motif of aspartyl hydroxylase identified by this analysis. This motifin vertebrates is characterized in part by an invariant histidine, proline, and conserved basic residue (lysine or arginine).
Other regions of interest include the MHPG sequence containing an invariant glycine residue and the highly conserved dibasic-glycine region (Fig. 2) .
The alignment of these conserved regions suggests that they may function in an aspect of the catalytic mechanism common to these enzymes. When the invariant histidine-675 of the His-2 motif of Asp (Asn) (-hydroxylase was mutated to an alanine (H675A), no enzymatic activity was detected in the resulting mutant Asp (Asn) 3-hydroxylase. (In these assays, the protein levels were increased >10-fold from standard assay conditions so that 1% ofthe wild-type activity could be detected.) This result supports the hypothesis based upon the sequence alignments that the region of the primary structure in the vicinity of the His-2 motif is important for enzymatic activity. Although the H675A mutant does not possess detectable enzymatic activity, the binding of Fe2+/ a-ketoglutarate to this mutant can be determined by monitoring the ability of Fe2+/a-ketoglutarate to prevent the incorporation of radioactivity from iodo[14Cjacetamide into the mutant protein, since protection from labeling was observed for the wild type ( Fig. 1; Table 3 ). The wild-type and mutant P52 proteins were incubated with iodo[14Clacetamide in the presence and absence of Fe2+/a-ketoglutarate and subjected to SDS/PAGE (Fig. 3) . In the absence of Fe2+/aketoglutarate, the amount of incorporated radioactivity (as well as the rate of incorporation; data not shown) was the same for the wild-type and mutant proteins (Fig. 3 legend) .
However, in the presence of Fe2+/a-ketoglutarate, 79%o
protection from labeling was observed for the wild type, in 
Multiple sequence alignment of the C-terminal regions of vertebrate a-ketoglutarate-dependent dioxygenases. A multiple sequence alignment of the C-terminal regions of the human prolyl (26) and lysyl (27) and chicken prolyl (28) and lysyl (29) hydroxylase sequences was generated using the Genetics Computer Group program PILEUP (30) . A pairwise alignment of the C-terminal regions of the bovine Asp (Asn) (3-hydroxylase sequence and the human lysyl hydroxylase sequence was generated by the GAP program using default parameters and the Dayhoff mutation matrix as implemented in the Genetics Computer Group package (30) . This alignment was used to align the bovine Asp (Asn) ,B-hydroxylase sequence by means of the program LINEUP (30) . Additionally, a gap was introduced to align proline-678 of Asp agreement with the aforementioned results ( Fig. 1; Table 3 ), while no appreciable protection from labeling was observed for the mutant. The most direct explanation for this result is that the mutant protein does not bind Fe2+/a-ketoglutarate.
The CD or intrinsic fluorescence spectra of the wild-type and H675A mutant proteins (purified to homogeneity) show no significant differences (data not shown). Furthermore, the thermal melt of both proteins as monitored by CD at 222 nm gave midpoint values of 50 ± PC and 49 1C, which are not significantly different. Although these results indicate that no major structural changes have taken place as a result of the H675A mutation, relatively small changes specific to the microenvironment of position 675 could have occurred that would not be detected by these methods. Therefore, in the absence of more precise structural data such as an x-ray structure, such changes cannot be excluded as a possible reason for the loss of enzymatic activity and Fe2+/aketoglutarate binding.
Since we have shown that for the wild-type protein, Fe2+ alone does not protect and a-ketoglutarate in the absence of Fe2+ (presence of EDTA) does not protect, we cannot formally determine whether the H675A mutation directly affects Fe2+ or a-ketoglutarate binding or both. Nevertheless, these studies strongly suggest a role for the His-2 motif (31) in catalysis and indicate several additional residues that would be likely candidates for site-directed mutagenesis to probe the catalytic mechanism of a-ketoglutarate-dependent dioxygenases.
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